vs
AMERISAFE INC（AMSF）与PROCEPT BioRobotics Corp（PRCT）财务数据对比。点击上方公司名可切换其他公司
PROCEPT BioRobotics Corp的季度营收约是AMERISAFE INC的1.0倍（$83.1M vs $80.1M），AMERISAFE INC净利率更高（10.2% vs -38.1%，领先48.2%），PROCEPT BioRobotics Corp同比增速更快（20.2% vs 10.3%），过去两年PROCEPT BioRobotics Corp的营收复合增速更高（24.8% vs 2.8%）
AMERISAFE Inc.是一家专业工伤保险服务商，核心经营市场为美国，覆盖本土49个州，主要为建筑、伐木、货运、制造等高风险行业的中小企业提供定制化工伤险产品及配套风险管理解决方案。
PROCEPT BioRobotics是一家专注于研发和商业化泌尿外科手术机器人解决方案的医疗科技企业，其旗舰AquaBeam系统可为良性前列腺增生患者提供图像引导微创治疗，服务覆盖北美、欧洲等地区的医疗机构与患者。
AMSF vs PRCT — 直观对比
营收规模更大
PRCT
是对方的1.0倍
$80.1M
营收增速更快
PRCT
高出9.9%
10.3%
净利率更高
AMSF
高出48.2%
-38.1%
两年增速更快
PRCT
近两年复合增速
2.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $80.1M | $83.1M |
| 净利润 | $8.1M | $-31.6M |
| 毛利率 | — | 64.9% |
| 营业利润率 | — | -4.1% |
| 净利率 | 10.2% | -38.1% |
| 营收同比 | 10.3% | 20.2% |
| 净利润同比 | -9.0% | -27.9% |
| 每股收益（稀释后） | $0.43 | $-0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMSFPRCT
| Q1 26 | $80.1M | $83.1M | ||
| Q4 25 | $81.6M | $76.4M | ||
| Q3 25 | $82.0M | $83.3M | ||
| Q2 25 | $81.1M | $79.2M | ||
| Q1 25 | $72.6M | $69.2M | ||
| Q4 24 | $74.0M | $68.2M | ||
| Q3 24 | $78.7M | $58.4M | ||
| Q2 24 | $75.8M | $53.4M |
净利润AMSFPRCT
| Q1 26 | $8.1M | $-31.6M | ||
| Q4 25 | $10.4M | $-29.8M | ||
| Q3 25 | $13.8M | $-21.4M | ||
| Q2 25 | $14.0M | $-19.6M | ||
| Q1 25 | $8.9M | $-24.7M | ||
| Q4 24 | $13.2M | $-18.9M | ||
| Q3 24 | $14.3M | $-21.0M | ||
| Q2 24 | $11.0M | $-25.6M |
毛利率AMSFPRCT
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
营业利润率AMSFPRCT
| Q1 26 | — | -4.1% | ||
| Q4 25 | 15.6% | -40.6% | ||
| Q3 25 | 21.3% | -27.8% | ||
| Q2 25 | 21.5% | -28.0% | ||
| Q1 25 | 15.5% | -39.7% | ||
| Q4 24 | 22.7% | -28.9% | ||
| Q3 24 | 22.6% | -38.4% | ||
| Q2 24 | 18.1% | -50.3% |
净利率AMSFPRCT
| Q1 26 | 10.2% | -38.1% | ||
| Q4 25 | 12.8% | -39.1% | ||
| Q3 25 | 16.9% | -25.7% | ||
| Q2 25 | 17.2% | -24.7% | ||
| Q1 25 | 12.3% | -35.8% | ||
| Q4 24 | 17.8% | -27.6% | ||
| Q3 24 | 18.2% | -35.9% | ||
| Q2 24 | 14.5% | -48.0% |
每股收益（稀释后）AMSFPRCT
| Q1 26 | $0.43 | $-0.56 | ||
| Q4 25 | $0.55 | $-0.54 | ||
| Q3 25 | $0.72 | $-0.38 | ||
| Q2 25 | $0.73 | $-0.35 | ||
| Q1 25 | $0.47 | $-0.45 | ||
| Q4 24 | $0.69 | $-0.34 | ||
| Q3 24 | $0.75 | $-0.40 | ||
| Q2 24 | $0.57 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.2M | $245.6M |
| 总债务越低越好 | — | $51.7M |
| 股东权益账面价值 | $246.6M | $347.7M |
| 总资产 | — | $487.1M |
| 负债/权益比越低杠杆越低 | — | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资AMSFPRCT
| Q1 26 | $34.2M | $245.6M | ||
| Q4 25 | $61.9M | $286.5M | ||
| Q3 25 | $54.7M | $294.3M | ||
| Q2 25 | $48.5M | $302.7M | ||
| Q1 25 | $44.8M | $316.2M | ||
| Q4 24 | $44.1M | $333.7M | ||
| Q3 24 | $63.7M | $196.8M | ||
| Q2 24 | $30.6M | $214.1M |
总债务AMSFPRCT
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
股东权益AMSFPRCT
| Q1 26 | $246.6M | $347.7M | ||
| Q4 25 | $251.6M | $365.9M | ||
| Q3 25 | $274.8M | $380.3M | ||
| Q2 25 | $265.6M | $385.8M | ||
| Q1 25 | $260.8M | $389.2M | ||
| Q4 24 | $257.3M | $402.2M | ||
| Q3 24 | $314.4M | $241.2M | ||
| Q2 24 | $301.0M | $251.8M |
总资产AMSFPRCT
| Q1 26 | — | $487.1M | ||
| Q4 25 | $1.1B | $508.1M | ||
| Q3 25 | $1.2B | $511.5M | ||
| Q2 25 | $1.2B | $513.1M | ||
| Q1 25 | $1.2B | $519.4M | ||
| Q4 24 | $1.2B | $534.0M | ||
| Q3 24 | $1.3B | $374.1M | ||
| Q2 24 | $1.2B | $374.4M |
负债/权益比AMSFPRCT
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMSF
暂无分部数据
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
